Navigation Links
Combination therapy reduced HER2-positive breast cancers
Date:12/10/2010

SAN ANTONIO A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12. Full results were presented at the symposium during a press briefing on Dec. 10, 2010, at 8:00 a.m. CT.

Reporters who cannot attend in person can participate using the following call-in information:

  • U.S. and Canada: (888) 282-7404
  • International: (706) 679-5207
  • Access Code: 25346432

Lead researcher Jos Baselga, M.D., Ph.D., chief of the division of hematology and oncology and associate director of the Massachusetts General Hospital Cancer Center, said early data indicate a 50 percent rate of pathological complete remission compared with 20 percent for either agent alone.

"This study suggests that a dual blockade against HER2 is an efficient way to target HER2-positive breast tumors and that lapatinib adds to trastuzumab. While further research is ongoing, our results indicate that we are on the right track to improve the therapy of HER2-positive disease," said Baselga, who is also a founding editor-in-chief of the AACR's newest journal Cancer Discovery, along with Lewis C. Cantley, Ph.D.

These results are from the NeoALTTO Trial, an international, multicenter, randomized study comparing the efficacy of lapatinib plus paclitaxel vs. trastuzumab plus paclitaxel vs. a combination of all three agents as neoadjuvant chemotherapy among 455 patients with HER2-positive breast cancer.

"It has been suggested in basic science research and smaller clinical trials that the combination of these therapies would be more effective than either alone, but this is the first time it has been shown in a large clinical trial setting," said Baselga.

At the symposium, Baselga presented the primary outcome of tu
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer
2. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
3. Grape news: New treatment combination safe alternative to sulfur dioxide
4. Study: Grass, fungus combination affects ecology
5. Investigators identify cleat/natural grass combination may be less likely to result in ACL injury
6. Diabetes drug kills cancer stem cells in combination treatment in mice
7. Old stain in a new combination
8. Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer
9. Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
10. Virginia Tech engineers introduce thermotherapy as a chemotherapy alternative
11. Never-smokers fare far better than smokers after radiation therapy for head and neck cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Warwick have discovered that ,good, cholesterol is turned ,bad, ... - MG, was found to damage ,good, HDL cholesterol, ... body. , Low levels of HDL, High Density ... levels of MG being common in the elderly and ... by funding from the British Heart Foundation (BHF) and ...
(Date:8/31/2014)... busy attacking us, germs go after each other. But ... for the infected microbes: Sometimes viruses actually carry helpful ... its diet or better attack its own hosts. , ... system would robotically destroy anything it recognized as invading ... now revealed that one variety of the bacterial immune ...
(Date:8/31/2014)... French . Montral, ... prestigious Nature Neuroscience journal by, Sylvain Williams, PhD, ... Mental Health University Institute and McGill University, opens the door ... controlling memory as well of the role of an essential ... , In 2009, they developed a unique approach ...
Breaking Biology News(10 mins):Sugar substance 'kills' good HDL cholesterol, new research finds 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 2Discovery reveals how bacteria distinguish harmful vs. helpful viruses 3Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms 2
... can greatly impact biological species and ecosystems, requiring ... accommodate habitat shifts. Recorded data already show ... regions where their climatic requirements are better met. ... regulators on climate change implications for local conservation, ...
... continue to be energy-intensive and highly polluting for the foreseeable ... the agenda, according to a study published in the ... Xia of Dongbei University of Finance and Economics and the ... has looked at almost a decade,s worth of data from ...
... in the Department of Chemistry and Biochemistry at the ... Career Development Award from the National Science Foundation (NSF) ... to study the biophysics of model cell membranes, with ... will support the purchase of a computer cluster for ...
Cached Biology News:Workshop to focus on conservation management and climate change 2Polluting China for the sake of economic growth 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 2Patel recognized with NSF Career Award for computer-modeling research on cell membranes 3
(Date:8/29/2014)... Pittcon is pleased to announce that the 2015 ... Scientific, have organized a session on nanotechnology for presentation ... Asia’s largest analytical and scientific instruments show, will be ... , The four speakers in this U.S. symposium, “Thinking ... Single Cells” will present their use of nanotechnology to ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... August 29, 2014 Due to a misstatement ... week, the Adult Stem Cell Technology Center, LLC ( ASCTC ... stem cell therapy research that might benefit ALS patients. ... for new stem cell technologies and therapeutic applications, FRC listed ... Bucket Challenge donors who wish not to support research ...
(Date:8/29/2014)... Boston, MA, San Antonio, TX (PRWEB) August 29, ... audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® ... it has been awarded an international Phase II ... patients with non-Hodgkin’s lymphoma. , Throughout this trial, ... services including, but not limited to, protocol and ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... May 14 StemCor Systems, Inc., a,medical device ... today that it has been awarded a,National Institutes ... Grant entitled "Adult Stem Cell Minimally Invasive Bone ... MarrowMiner(TM) which,recently received 510(k) clearance from the U.S. ...
... 2008 - A team of five University of Akron ... role of temperature and humidity in PLoS ONE, an ... , The UA authors are Dr. Peter Niewiarowski, professor ... Ge, graduate assistant in polymer science; Emily Hagan (undergraduate ...
... Flow Cytometry Platforms, FRANKLIN LAKES, N.J., May 13 ... announced today that it has acquired all,of the outstanding ... Seattle that develops and markets advanced flow,cytometry cell sorting ... disclosed. The acquisition,is not expected to have a material ...
Cached Biology Technology:StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 2StemCor Systems, Inc. Awarded NIH SBIR Grant for Bone Marrow Aspiration Platform 3BD Announces Acquisition of Cytopeia 2BD Announces Acquisition of Cytopeia 3
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Defender against cell death 1...
Wnt-1 (G-19)...
Biology Products: